Results 191 to 200 of about 306,000 (257)

The effect of alcohol withdrawal therapy on gut microbiota in alcohol use disorder and its link to inflammation and craving. [PDF]

Alcohol Clin Exp Res (Hoboken)
Proskynitopoulos PJ, Woltemate S, Rhein M, Böke I, Molks J, Schröder S, Schneider HU, Bleich S, Frieling H, Geffers R, Glahn A, Vital M.   +11 more
europepmc   +1 more source

Effective acetalization of furfural catalyzed by Fe‐ and Co‐oxalates: impact of alcohols structure on products composition

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract Fe‐, Co‐, and FeCo‐oxalates supported on silica gel (5 wt% metal load) were synthesized, characterized, and tested for the first time in solvent‐free furfural (FF) acetalization with C1–C8 alcohols at 70–170 °C under both conventional and microwave (MW)‐assisted conditions. The interaction of FF with linear C1–C4 alcohols yielded pincer‐shaped
Alexander Pokutsa, Katarzyna Rydel‐Ciszek, Alina M. Balu, Rafael Luque   +3 more
wiley   +1 more source

Successful Use of Impella Support to Treat Cardiogenic Shock Secondary to Takotsubo Cardiomyopathy Owing to Alcohol Withdrawal. [PDF]

Cureus
Takeuchi Y, Sato T.
europepmc   +1 more source

Psychoactive prescription drug use and misuse in patients on opioid agonist treatment

British Journal of Clinical Pharmacology, EarlyView.
Aims To identify the patterns and trends in prescription drug use and misuse in patients on opioid agonist treatment. Methods We used data from the OPPIDUM programme, which collects data from patients attending substance abuse treatment facilities. Data collected include use of psychoactive prescription drugs in the past week.
Thomas Soeiro, Clémence Lacroix, Élisabeth Jouve, Élisabeth Frauger, Maryse Lapeyre‐Mestre, Joëlle Micallef   +5 more
wiley   +1 more source

An open‐label, single‐arm, dose‐escalating concentration–QT study to investigate the cardiac effects and safety of paroxetine in healthy adults

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Paroxetine is a selective serotonin reuptake inhibitor (SSRI), approved for treatment of major depressive disorder and anxiety disorders. Some SSRIs are known to prolong the QT interval; however, clinical evidence to establish a lack of association between paroxetine and corrected QT interval (QTc) prolongation is limited. Therefore, this
Sven C. van Dijkman, Mathieu Félices, Bhaskar Pandurangavittal, Sanman Ghorpade, Caroline Easterbrook, Marcin Zabielski, Oscar Della Pasqua   +6 more
wiley   +1 more source

Appropriateness, feasibility, and adoption of a nurse-driven CIWA-Ar symptom-triggered protocol for alcohol withdrawal syndrome in New York City public hospitals. [PDF]

Am J Med Open
King C, Shen MS, Bayani J, Schatz D.
europepmc   +1 more source

Low‐dose cannabidiol increases plasma concentrations of amitriptyline: A clinical drug–drug interaction study

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Cannabidiol (CBD), the main non‐intoxicating compound from the cannabis plant, is regularly used by patients with chronic pain who also take analgesics. CBD has previously been shown to inhibit CYP‐mediated drug metabolism. This study aimed to characterize the potential pharmacokinetic interaction of CBD with amitriptyline and tramadol ...
Andriy A. Gorbenko, Titiaan E. Post, Pamela K. Strugala, Erica S. Klaassen, Linda E. Klumpers, Saco J. de Visser, Cristina Sempio, Jost Klawitter, Jules A. A. C. Heuberger, Geert J. Groeneveld   +9 more
wiley   +1 more source

Hospital-Wide Implementation, Clinical Outcomes, and Safety of Phenobarbital for Alcohol Withdrawal.

JAMA Netw Open
Wolpaw BJ, Oren H, Quinnan-Hostein L, Bradley KA, Johnson NJ, Hallgren KA, Gupta A, Kim HN, Granich MA, Steel TL.   +9 more
europepmc   +1 more source

Respiratory Failure Requiring Mechanical Ventilation Among Patients Receiving Chlordiazepoxide for Alcohol Withdrawal Symptoms. [PDF]

Acta Anaesthesiol Scand
Reiter N, Otte HR, Dalhoff K, Wamberg CA, Petersen TS, Meyhoff CS.   +5 more
europepmc   +1 more source